These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1126 related items for PubMed ID: 26989832
1. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction. Biron VL, Kostiuk M, Isaac A, Puttagunta L, O'Connell DA, Harris J, Côté DW, Seikaly H. Cancer; 2016 May 15; 122(10):1544-51. PubMed ID: 26989832 [Abstract] [Full Text] [Related]
3. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis. Laborde RR, Janus JR, Olsen SM, Wang VW, Garcia JJ, Graham RP, Moore EJ, Olsen KD, Kasperbauer JL, Price DL, Berres M, Halling G, Smith DI. Laryngoscope; 2012 Dec 15; 122(12):2707-11. PubMed ID: 22961429 [Abstract] [Full Text] [Related]
4. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study. Economopoulou P, Koutsodontis G, Avgeris M, Strati A, Kroupis C, Pateras I, Kirodimos E, Giotakis E, Kotsantis I, Maragoudakis P, Gorgoulis V, Scorilas A, Lianidou E, Psyrri A. PLoS One; 2019 Dec 15; 14(5):e0215984. PubMed ID: 31071126 [Abstract] [Full Text] [Related]
5. Biomarkers of HPV in head and neck squamous cell carcinoma. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. Cancer Res; 2012 Oct 01; 72(19):5004-13. PubMed ID: 22991304 [Abstract] [Full Text] [Related]
6. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH. Int J Cancer; 2014 May 15; 134(10):2366-72. PubMed ID: 24249631 [Abstract] [Full Text] [Related]
7. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Rooper LM, Gandhi M, Bishop JA, Westra WH. Oral Oncol; 2016 Apr 15; 55():11-6. PubMed ID: 27016012 [Abstract] [Full Text] [Related]
9. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, Koch W, Richmon JD, Eisele DW, D'Souza G. Cancer; 2017 May 01; 123(9):1566-1575. PubMed ID: 28241096 [Abstract] [Full Text] [Related]
10. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Linge A, Schötz U, Löck S, Lohaus F, von Neubeck C, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Bunea H, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Lauber K, Pigorsch S, Combs SE, Mönnich D, Zips D, Baretton GB, Buchholz F, Krause M, Belka C, Baumann M, DKTK-ROG. Radiother Oncol; 2018 Apr 01; 127(1):27-35. PubMed ID: 29295747 [Abstract] [Full Text] [Related]
11. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS. Hum Pathol; 2013 Nov 01; 44(11):2385-92. PubMed ID: 24071016 [Abstract] [Full Text] [Related]
13. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH. Am J Surg Pathol; 2012 Dec 01; 36(12):1874-82. PubMed ID: 23060353 [Abstract] [Full Text] [Related]
14. Quantitative polymerase chain reaction-based detection of HPV 16 E6 and E7 DNA in oral squamous cell carcinoma. Thammaiah S, Venkobarao MC, Sathyavanthan H, Mirnalini AS. J Oral Pathol Med; 2018 Oct 01; 47(9):873-879. PubMed ID: 30059164 [Abstract] [Full Text] [Related]
15. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Holzinger D, Wichmann G, Baboci L, Michel A, Höfler D, Wiesenfarth M, Schroeder L, Boscolo-Rizzo P, Herold-Mende C, Dyckhoff G, Boehm A, Del Mistro A, Bosch FX, Dietz A, Pawlita M, Waterboer T. Int J Cancer; 2017 Jun 15; 140(12):2748-2757. PubMed ID: 28316084 [Abstract] [Full Text] [Related]
16. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Am J Surg Pathol; 2012 Jul 15; 36(7):945-54. PubMed ID: 22743284 [Abstract] [Full Text] [Related]